Vyant Bio Inc. sell Global_Player
Start price
30.03.22
/
50%
€8.50
Target price
30.03.23
-
Performance (%)
-24.12%
End price
31.03.22
€6.45
Summary
This prediction ended on 31.03.22 with a price of €6.45. The prediction for Vyant Bio Inc. closed with a convincing performance of -24.12%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vyant Bio Inc. | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to Global_Player what are the pros and cons of Vyant Bio Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Cancer Genetics Inc. diskutieren
Sell Vyant Bio Inc.